THRα1 immunolabelling was reduced by 33% in SCT of GDM placenta vs. controls (p = 0.046; median IRS: GDM 6 vs. control 9) without changes (p < 0.05) in other cell types. This evidence concerns the gene THRA and gestational diabetes.